Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

Vendor product quality

How Come My Gel Bands Aren't that Discrete?

Bogger Jade Ed said the "same standards for good scientific practice" that research groups must adhere to when reporting results should also apply to life science vendors that are marketing products, only high-quality, accurate data should accompany the images in their ads. S. Pelech reports that when tested by Kinexus more than 80% of 3500 commercial antibodies from over 25 different vendors were determined to be either impotent (i.e. weak), non-specific ("dirty") or both. The wide dissemination of such poor reagents ultimately results in a lot of wasted time, money and effort, and is a great disservice to the scientific community. Read More...